2022 - Research.com Best Scientist Award
Member of the Association of American Physicians
His main research concerns Internal medicine, Colorectal cancer, Prospective cohort study, Cancer and Oncology. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery. His Colorectal cancer research incorporates elements of Cancer research, Molecular pathological epidemiology, Microsatellite instability and Pathology.
His research integrates issues of Lower risk, Endocrinology, Incidence and Immunology in his study of Prospective cohort study. His work in the fields of Cancer, such as Cetuximab, intersects with other areas such as Risk assessment. Charles S. Fuchs interconnects Tumor microenvironment, Irinotecan, Fluorouracil and PTPRC in the investigation of issues within Oncology.
His scientific interests lie mostly in Internal medicine, Colorectal cancer, Oncology, Cancer and Prospective cohort study. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Surgery. His Colorectal cancer research is multidisciplinary, relying on both Lower risk, Cancer research, Molecular pathological epidemiology and Microsatellite instability.
His work deals with themes such as Pembrolizumab, Odds ratio, Chemotherapy, Pancreatic cancer and Adenocarcinoma, which intersect with Oncology. His Cancer study incorporates themes from Aspirin, Gynecology, Disease and Cohort. In his research, Epidemiology is intimately related to Cohort study, which falls under the overarching field of Prospective cohort study.
Charles S. Fuchs focuses on Internal medicine, Oncology, Colorectal cancer, Cancer and Hazard ratio. His Internal medicine study frequently intersects with other fields, such as Gastroenterology. Charles S. Fuchs works mostly in the field of Oncology, limiting it down to topics relating to Pancreatic cancer and, in certain cases, Genome-wide association study and Single-nucleotide polymorphism.
His Colorectal cancer research is multidisciplinary, incorporating perspectives in Lower risk, Cancer research, Molecular pathological epidemiology and Microsatellite instability. His study in Cancer is interdisciplinary in nature, drawing from both Aspirin, Placebo and Carcinoma. His research integrates issues of Body mass index, Incidence, Survival rate, Quartile and Survival analysis in his study of Hazard ratio.
Charles S. Fuchs mainly focuses on Internal medicine, Colorectal cancer, Oncology, Cancer and Hazard ratio. His study in Gastroenterology extends to Internal medicine with its themes. The study incorporates disciplines such as Lower risk, Cancer research, Molecular pathological epidemiology and Microsatellite instability in addition to Colorectal cancer.
The various areas that he examines in his Oncology study include Immune checkpoint, Pancreatic cancer, Immunology, Germline and Carcinoma. His Cancer study integrates concerns from other disciplines, such as Perioperative, Logistic regression and Group B. Charles S. Fuchs combines subjects such as Survival rate, Whole grains, Quartile, Randomized controlled trial and Risk factor with his study of Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S Fuchs;Jiri Tomasek;Cho Jae Yong;Filip Dumitru.
The Lancet (2014)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic;Aleksandar D. Kostic;Eunyoung Chun;Lauren Robertson;Jonathan N. Glickman.
Cell Host & Microbe (2013)
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
Edward Giovannucci;Yan Liu;Eric B. Rimm;Bruce W. Hollis.
Journal of the National Cancer Institute (2006)
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Reiko Nishihara;Kana Wu;Paul Lochhead;Teppei Morikawa.
The New England Journal of Medicine (2013)
Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
Edward Giovannucci;Meir J. Stampfer;Graham A. Colditz;David J. Hunter.
Annals of Internal Medicine (1998)
Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study
Charles S. Fuchs;John Marshall;Edith Mitchell;Rafal Wierzbicki.
Journal of Clinical Oncology (2007)
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
William G. Kaelin;Wilhelm Krek;William R. Sellers;James A. DeCaprio.
A Prospective Study of Family History and the Risk of Colorectal Cancer
Charles S. Fuchs;Edward L. Giovannucci;Graham A. Colditz;David J. Hunter.
The New England Journal of Medicine (1994)
Alcohol consumption and mortality among women
C. S. Fuchs;M. J. Stampfer;G. A. Colditz;E. L. Giovannucci.
The New England Journal of Medicine (1995)
Methylenetetrahydrofolate Reductase Polymorphism, Dietary Interactions, and Risk of Colorectal Cancer
Jing Ma;Meir J. Stampfer;Edward Giovannucci;Carmen Artigas.
Cancer Research (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: